A detailed history of Qube Research & Technologies LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Qube Research & Technologies LTD holds 779,300 shares of BMY stock, worth $45.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
779,300
Previous 4,690,379 83.39%
Holding current value
$45.1 Million
Previous $195 Million 79.3%
% of portfolio
0.06%
Previous 0.31%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $60.3 Million - $79.4 Million
1,498,953 Added 46.97%
4,690,379 $195 Million
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $168 Million - $191 Million
-3,503,168 Reduced 52.33%
3,191,426 $173 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $156 Million - $186 Million
3,208,186 Added 92.02%
6,694,594 $343 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $59.9 Million - $67 Million
1,035,243 Added 42.23%
3,486,408 $202 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $127 Million - $141 Million
1,986,534 Added 427.55%
2,451,165 $157 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $64.8 Million - $73.5 Million
-986,386 Reduced 67.98%
464,631 $32.2 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $99.4 Million - $118 Million
1,451,017 New
1,451,017 $104 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $74.2 Million - $81.7 Million
1,021,867 Added 2107.29%
1,070,359 $82.4 Million
Q1 2022

May 09, 2022

BUY
$61.48 - $73.72 $2.98 Million - $3.57 Million
48,492 New
48,492 $3.54 Million
Q4 2021

Feb 01, 2022

SELL
$53.63 - $62.52 $12.6 Million - $14.7 Million
-235,469 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $13.9 Million - $16.3 Million
235,469 New
235,469 $13.9 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $20.1 Million - $21.9 Million
-325,357 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $17.5 Million - $19.7 Million
294,817 Added 965.35%
325,357 $20.5 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $1.43 Million - $1.62 Million
24,717 Added 424.47%
30,540 $1.89 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $92,232 - $102,205
1,606 Added 38.08%
5,823 $351,000
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $231,175 - $270,267
4,217 New
4,217 $248,000
Q2 2019

Aug 02, 2019

SELL
$44.62 - $49.34 $2.71 Million - $2.99 Million
-60,669 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $2.74 Million - $3.26 Million
60,669 New
60,669 $2.9 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $1.03 Million - $1.34 Million
-21,221 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $1.05 Million - $1.19 Million
19,108 Added 904.31%
21,221 $1.32 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $83,222 - $103,728
-1,647 Reduced 43.8%
2,113 $117,000
Q1 2018

May 14, 2018

BUY
$59.92 - $68.98 $225,299 - $259,364
3,760 New
3,760 $237,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.